Specialty Pharmacy Drug List

Total Page:16

File Type:pdf, Size:1020Kb

Specialty Pharmacy Drug List Specialty Pharmacy Drug List Our Specialty Pharmacy provides patients with comprehensive support services and coordinated delivery related to high-cost oral, inhaled or injectable specialty medications, used to treat complex conditions. We are your single source for high-touch patient care management to control side effects, patient support and education to ensure compliance or continued treatment, and specialized handling and distribution of medications directly to the patient or care provider. Specialty medications may be covered under either the medical or pharmacy benefit. Please consult your insurance documentation to determine which benefit covers these medications. We offer a broad specialty medication list containing nearly 500 drugs, covering 42 therapeutic categories and specialty disease states. This list is updated with new information each quarter. Characteristics of Specialty Medications “Specialty” medications are defined as high-cost oral or injectable medications used to treat complex chronic conditions. These are highly complex medications, typically biology-based, that structurally mimic compounds found within the body. High-touch patient care management is usually required to control side effects and ensure compliance. Specialized handling and distribution are also necessary to ensure appropriate medication administration. Medications must have at least one of the following characteristics in order to be classified as a specialty medication by Magellan Rx Management. High Cost High Complexity High Touch High-cost medications are • Biotechnology products¥ • Medications that require temperature control or other special typically priced at more than • Orphan or Ultra-Orphan drugs handling/shipping requirements (i.e., refrigerated or frozen shipping) $1,000 per 30-day supply; • Medications that are included • Medications that require ongoing drug management by a pharmacist including self-administered in a specialty therapeutic drug and/or physician specializing in treating the member’s condition injectables, professionally- class strategy • Medications that require focused, in-depth member education, † administered injectables/ compliance monitoring, side effect management and, often, infusions, and oral medications injection technique education Generics: Lower case italic. For example, dexferrum Brands: All capital letters. For example, HUMIRA QL: Quantity Limits apply under some benefits. Check your plan document for coverage details. PA: Prior Authorization needed under some benefits. Check your plan document for coverage details. Anemia Asthma CAMPTOSAR epirubicin IFEX ARANESP ‡ PA XOLAIR PA capecitabine ERBITUX PA ifosfamide dexferrum CAPRELSA PA ERIVEDGE PA IMBRUVICA PA EPOGEN PA Birth Control carboplatin ERWINAZE INLYTA PA FERAHEME IMPLANON CERUBIDINE ETHYOL IRESSA PA, QL ferrlecit MIRENA cisplatin ETOPOPHOS irinotecan MIRCERA PA NEXPLANON cladribine etoposide ISTODAX PA OMONTYS PARAGARD T 380-A CLOLAR FARYDAK PA IXEMPRA PROCRIT ‡ PA SKYLA COMETRIQ PA FASLODEX JAKAFI PA COSMEGEN FIRMAGON PA JEVTANA PA sodium ferric gluconate Cancer/Chemotherapy VENOFER cyclophosphamide floxuridine KADCYLA PA ABRAXANE PA CYRAMZA PA FLUDARA KEYTRUDA PA ADCETRIS PA Anticoagulants cytarabine fludarabine KYPROLIS PA adriamycin ADEMPAS PA dacarbazine fluorouracil LENVIMA ‡ PA, QL adrucil ARIXTRA DACOGEN FOLOTYN PA LEUCOVORIN CALCIUM INJ AFINITOR PA enoxaparin DACTINOMYCIN FUSILEV LEUSTATIN ALIMTA PA IPRIVASK daunorubicin GABLOFEN LYNPARZA PA ALKERAN fondaparinux DAUNOXOME GAZYVA PA lipodox amifostine FRAGMIN decitabine gemcitabine MARQIBO PA ARRANON INNOHEP DEPOCYT GEMZAR MATULANE ARZERRA PA LOVENOX dexrazoxane PA GILOTRIF PA MEKINIST PA AVASTIN PA DOCEFREZ GLEEVEC* ‡ PA melphalan Antilipemic Agents azacitidine docetaxel HALAVEN PA mercaptopurine KYNAMRO PA BELEODAQ PA DOXIL HERCEPTIN PA mesna JUXTAPID PA BEXXAR doxorubicin hcl HYCAMTIN PA MESNEX PRALUENT ‡ PA, QL BICNU ELLENCE IBRANCE ‡ PA mitomycin REPATHA ‡ PA, QL bleomycin sulfate ELOXATIN ICLUSIG PA mitoxantrone TIKOSYN BOSULIF PA ELSPAR IDAMYCIN PFS MOZOBIL PA BUSULFEX EMCYT idarubicin hcl MUSTARGEN CAMPATH PA † Administered by a healthcare professional or in a healthcare setting ¥ Protein or protein-based molecular entities ‡ Preferred Specialty Product © 2016 Magellan Rx Management. All rights expressly reserved. This publication may not be reproduced in whole or part by any means whatsoever without express written permission of the copyright owner. MRX0367_0116 MYLERAN VESANOID Endocrine and Growth Hormone and THROMBATE III NAVELBINE VIDAZA Metabolic Agents Related Disorders tranexamic acid NEXAVAR ‡ PA, QL vinblastine sulfate ACTHREL PA GENOTROPIN PA TRETTEN PA NILANDRON PA, QL vincasar pfs AVEED PA HUMATROPE PA WILATE NIPENT vincristine sulfate KORLYM PA INCRELEX PA XYNTHA ‡ ODOMZO PA, QL vinorelbine tartrate LYSODREN NORDITROPIN ‡ PA ONCASPAR VORAXAZE MYALEPT PA NOVOEIGHT PA Hepatitis B adefovir dipivoxil OPDIVO PA VOTRIENT PA, QL EGRIFTA PA, QL NUTROPIN PA BARACLUDE QL oxaliplatin VUMON octreotide PA NUTROPIN AQ PA entecavir QL paclitaxel XALKORI PA, QL SAMSCA PA, QL OMNITROPE PA EPIVIR HBV ‡ pentostatin XELODA ‡ SANDOSTATIN PA SAIZEN PA lamivudine tab PERJETA PA XGEVA PA, QL SANDOSTATIN LAR PA SEROSTIM PA, QL NABI-HB PHOTOFRIN XOFIGO PA SENSIPAR SOMAVERT THROMBATE III POMALYST PA, QL XTANDI PA, QL SIGNIFOR PA TECHNIVIE PA, QL HEPAGAM B PROLEUKIN PA YERVOY PA SOMATULINE PA TEV-TROPIN PA HYPERHEP B S-D PROVENGE PA ZALTRAP PA SOMAVERT PA ZOMACTON ‡ PA HEPSERA ‡ PURIXAN PA ZANOSAR SYNAREL ZORBTIVE PA, QL TYZEKA REVLIMID PA, QL ZELBORAF PA, QL TESTOPEL PA Hemophilia and RITUXAN PA ZEVALIN THYROGEN Hepatitis C SIGNIFOR LAR PA ZINECARD PA Related Bleeding ACTIMMUNE SPRYCEL PA, QL ZOLADEX ‡ PA Enzyme Replacement Disorders ACTIVASE ALFERON N STIVARGA PA, QL ZOLINZA PA, QL (Alpha 1) ADVATE COPEGUS PA SUPPRELIN LA ZYDELIG PA, QL ADAGEN ALPHANATE DAKLINZA PA, QL SUTENT PA, QL ZYKADIA PA, QL ALDURAZYME PA ALPHANINE S/D HARVONI ‡ PA, QL SYLATRON PA ZYTIGA ‡ PA ARALAST PA ALPROLIX PA INCIVEK ‡ PA, QL SYNRIBO PA ELAPRASE PA ATRYN PA INFERGEN PA TABLOID Crohn’s Disease ELELYSO PA BEBULIN VH INTRON A PA TAFINLAR PA, QL CIMZIA PA, QL GLASSIA PA BENEFIX moderiba PA TARCEVA PA, QL HUMIRA ‡ PA, QL FABRAZYME PA BERINERT PA OLYSIO PA, QL TARGRETIN PA REMICADE ‡ PA KUVAN PA, QL PEG INTRON ‡ PA TARGRETIN GEL TYSABRI PA LUMIZYME PA CINRYZE PA PEGASYS PA TASIGNA ‡ PA, QL MYOZYME PA CORIFACT Cystic Fibrosis REBETOL PA TAXOTERE NAGLAZYME PA CYKLOKAPRON BETHKIS PA ribatab PA TEMODAR ‡ PA NATPARA ‡ PA ELOCTATE PA CAYSTON ribapak tablets kit PA temozolomide PA ORFADIN PA FEIBA NF ESBRIETA PA ribasphere PA teniposide ORKAMBI ‡ PA, QL FIRAZYR PA KALYDECO PA, QL ribavirin PA THALOMID PA, QL PROCYSBI HELIXATE FS KITABIS PA SOVALDI ‡ PA, QL THERACYS PROLASTIN PA HEMOFIL-M OFEV PA, QL TECHNIVIE PA, QL THIOTEPA SOLESTA HUMATE-P PULMOZYME PA, QL VIEKIRA PA, QL TICE BCG VIMIZIM IXINITY PA TOBI VICTRELIS PA, QL toposar ZEMAIRA PA KALBITOR PA TOBI PODHALER topotecan KOATE-DVI tobramycin nebu soln Gastrointestinal HIV/AIDS TORISEL PA, QL KOGENATE FS Agents abacavir TOTECT PA LYSTEDA QL Cytomegalovirus CHOLBAM ‡ PA, QL abacavir sulfate TREANDA PA MONOCLATE-P Vaccines GATTEX PA abacavir sulfate/lamivudine/ tretinoin PA, QL MONONINE zidovudine CYTOGAM SUCRAID TRISENOX PA NOVOSEVEN RT APTIVUS ‡ TYKERB ‡ PA, QL Dystonia Gaucher Disease OBIZUR ATRIPLA ‡ PROFILNINE UNITUXIN ‡ PA BOTOX PA CERDELGA PA, QL COMBIVIR RECOMBINATE UVADEX DYSPORT PA CEREZYME PA COMPLERA ‡ RECOTHROM VALCHLOR PA, QL MYOBLOC PA VPRIV PA CRIXIVAN ‡ RIASTAP VALSTAR XIAFLEX ZAVESCA PA didanosine VANTAS zoledronic RIXUBIS EDURANT ‡ VECTIBIX PA RUCONEST PA EMTRIVA ‡ VELCADE PA STIMATE EPIVIR ‡ © 2016 Magellan Rx Management. All rights expressly reserved. This publication may not be reproduced in whole or part by any means whatsoever without express written permission of the copyright owner. MRX0367_0116 EPZICOM ‡ Hyperparathyroidism Infertility Narcolepsy Pain Management FUZEON QL doxercalciferol BRAVELLE PA XYREM PA, QL LIORESAL INT INTELENCE ‡ HECTOROL CETROTIDE ‡ PA PRIALT INVIRASE ‡ ZEMPLAR CHORIONIC Nausea QUTENZA ISENTRESS ‡ GONADOTROPIN PA AKYNZEO PA KALETRA ‡ Immune Deficiency BENLYSTA PA ALOXI Parkinson Disease lamivudine BIVIGAM PA ENDOMETRIN VAGINAL ‡ ANZEMET QL APOKYN PA lamivudine/ zidovudine CARIMUNE NF PA GANIRELIX CESAMET PA Psoriasis LEXIVA ‡ FLEBOGAMMA PA GONAL-F ‡ PA EMEND QL COSENTYX PA nevirapine GAMASTAN S/D PA GONAL-F RFF ‡ PA granisetron ENBREL ‡ PA, QL NORVIR GAMMAGARD PA MAKENA ‡ PA ONDANSETRON HCL INJ HUMIRA ‡ PA, QL PREZISTA ‡ GAMMAGARD SD PA MENOPUR PA SANCUSCO QL REMICADE ‡ PA RESCRIPTOR GAMMAKED PA novarel PA ZOFRAN INJ RASUVO PA,QL RETROVIR GAMMAPLEX PA OVIDREL ‡ PA Neuromuscular STELARA PA, QL REYATAZ ‡ GAMUNEX PA pregnyl PA Blocking Agent SELZENTRY ‡ PA HIZENTRA PA REPRONEX PA XEOMIN PA Pulmonary stavudine HYPERRAB S/D Hypertension HYPERRHO S/D Iron Overload STRIBILD Neutropenia ADCIRCA PA, QL HYPERTET S/D EXJADE SUSTIVA ‡ GRANIX PA epoprostenol PA HYQVIA PA FERRIPROX PA TIVICAY LEUKINE PA FLOLAN PA IMOGAM RABIES TRIUMEQ PA Miscellaneous NEULASTA‡ PA LETAIRIS ‡ PA, QL MICRHOGAM PL TRIZIVIR AMYVID NEUPOGEN‡ PA OPSUMIT PA, QL OCTAGAM PA TRUVADA ‡ BENLYSTA PA ZARXIO PA, QL ORENITRAM PA PRIVIGEN PA TYBOST ‡ PA CARBAGLU REMODULIN PA SOLIRIS Ophthalmic VIDEX ‡ cidofovir REVATIO PA, QL VIDEX EC EYLEA Immune Globulins — CRESEMBA INJ ‡ PA sildenafil 20mg PA, QL VIRACEPT ‡ JETREA PA Obstetrics CYSTAGON TRACLEER ‡ PA, QL VIRAMUNE LUCENTIS RHOGAM PLUS CYTOVENE TYVASO PA, QL VIRAMUNE XR ‡ MACUGEN RHOPHYLAC ELITEK VELETRI
Recommended publications
  • Immunology New Orleans, LA Toll Free 888.355.4191 Toll Free Fax 888.355.4192 Krogerspecialtypharmacy.Com
    Immunology New Orleans, LA toll free 888.355.4191 toll free fax 888.355.4192 krogerspecialtypharmacy.com Need By Date: _________________________________________________ Ship To: Patient Office Fax Copy: Rx Card Front/Back Clinical Notes Medical Card Front/Back Patient Information Prescriber Information Patient Name Prescriber Name Address Address City State Zip City State Zip Main Phone Alternate Phone Phone Fax Social Security # Contact Person Date of Birth Male Female DEA # NPI # License # Clinical Information Diagnosis: J45.40 Moderate Asthma J45.50 Severe Asthma L20.9 Atopic Dermatitis L50.1 Chronic Idiopathic Urticaria (CIU) Eosinophil Levels J33 Chronic Rhinosinusitis with Nasal Polyposis Other: ________________________________ Dx Code: ___________ Drug Allergies Concomitant Therapies: Short-acting Beta Agonist Long-acting Beta Agonist Antihistamines Decongestants Immunotherapy Inhaled Corticosteroid Leukotriene Modifiers Oral Steroids Nasal Steroids Other: _____________________________________________________________ Please List Therapies Weight kg lbs Date Weight Obtained Lab Results: History of positive skin OR RAST test to a perennial aeroallergen Pretreatment Serum lgE Level: ______________________________________ IU per mL Test Date: _________ / ________ / ________ MD Specialty: Allergist Dermatologist ENT Pediatrician Primary Care Prescription Type: Naïve/New Start Restart Continued Therapy Pulmonologist Other: _________________________________________ Last Injection Date: _________ / ________
    [Show full text]
  • Clinical Pharmacy Specialist
    SAMPLE JOB DESCRIPTION Clinical Pharmacist Specialist I. JOB SUMMARY The Clinical Pharmacist Specialists are responsible and accountable for the provision of safe, effective, and prompt medication therapy. Through various assignments within the department, they provide support of centralized and decentralized medication-use systems as well as deliver optimal medication therapy to patients with a broad range of disease states. Clinical Pharmacist Specialists proficiently provide direct patient-centered care and integrated pharmacy operational services in a decentralized practice setting with physicians, nurses, and other hospital personnel. These clinicians are aligned with target interdisciplinary programs and specialty services to deliver medication therapy management within specialty patient care services and to ensure pharmaceutical care programs are appropriately integrated throughout the institution. In these clinical roles, Clinical Pharmacist Specialists participate in all necessary aspects of the medication-use system while providing comprehensive and individualized pharmaceutical care to the patients in their assigned areas. Pharmaceutical care services include but are not limited to assessing patient needs, incorporating age and disease specific characteristics into drug therapy and patient education, adjusting care according to patient response, and providing clinical interventions to detect, mitigate, and prevent medication adverse events. Clinical Pharmacist Specialists serve as departmental resources and liaisons to other
    [Show full text]
  • Optumrx Mail Order Service
    Mail Service Pharmacy Program OptumRx™ Mail Service Pharmacy makes ordering maintenance medications easy and saves you both time and money compared to a retail pharmacy. Using your mail order benefit entitles you to a 90-day supply at a discounted price, where through a retail pharmacy you receive a 30-day supply. Plus, shipping is at no cost to you — so you do not have to drive to your local pharmacy. • Save time • Save money • Convenient door-to-door service OptumRx uses generic products whenever possible to help reduce your medication costs. Generic medications are FDA approved equivalents to the more expensive brand-name version. If you or your physician prefers the brand-name, please indicate this on your order. Please be aware that the brand-name medication may be subject to a higher copay as determined by your Plan. Contact Customer Service for information about your copays. Mail Service Pharmacy Program Your Medication Safety Is Protected by Our Professional Staff Every prescription submitted to OptumRx is screened by our team of registered pharmacists for accuracy, drug interactions, allergies and appropriateness of therapy. OptumRx maintains a complete record of all of your current medications, regardless of where you had them filled.* If for any reason we believe your prescription needs clarification, we will contact you or your physician. If we are unable to resolve the issue and we anticipate a delay in shipping your order, we will contact you. • Professional staff • Accuracy • Quality • Medication screening Four Ways to Get Started Using Mail Service 1 Your Physician Can Fax Us If you would like to save mailing time to OptumRx, your physician can fax your prescriptions directly to our processing center at 1-800-491-7997, 24 hours a day, 7 days a week.
    [Show full text]
  • STEM Disciplines
    STEM Disciplines In order to be applicable to the many types of institutions that participate in the HERI Faculty Survey, this list is intentionally broad and comprehensive in its definition of STEM disciplines. It includes disciplines in the life sciences, physical sciences, engineering, mathematics, computer science, and the health sciences. Agriculture/Natural Resources Health Professions 0101 Agriculture and related sciences 1501 Alternative/complementary medicine/sys 0102 Natural resources and conservation 1503 Clinical/medical lab science/allied 0103 Agriculture/natural resources/related, other 1504 Dental support services/allied 1505 Dentistry Biological and Biomedical Sciences 1506 Health & medical administrative services 0501 Biochem/biophysics/molecular biology 1507 Allied health and medical assisting services 0502 Botany/plant biology 1508 Allied health diagnostic, intervention, 0503 Genetics treatment professions 0504 Microbiological sciences & immunology 1509 Medicine, including psychiatry 0505 Physiology, pathology & related sciences 1511 Nursing 0506 Zoology/animal biology 1512 Optometry 0507 Biological & biomedical sciences, other 1513 Osteopathic medicine/osteopathy 1514 Pharmacy/pharmaceutical sciences/admin Computer/Info Sciences/Support Tech 1515 Podiatric medicine/podiatry 0801 Computer/info tech administration/mgmt 1516 Public health 0802 Computer programming 1518 Veterinary medicine 0803 Computer science 1519 Health/related clinical services, other 0804 Computer software and media applications 0805 Computer systems
    [Show full text]
  • ADHD Parents Medication Guide Revised July 2013
    ADHD Parents Medication Guide Revised July 2013 Attention-Deficit/Hyperactivity Disorder Prepared by: American Academy of Child & Adolescent Psychiatry and American Psychiatric Association Supported by the Elaine Schlosser Lewis Fund Physician: ___________________________________________________ Address: ___________________________________________________ ___________________________________________________ ___________________________________________________ Phone: ___________________________________________________ Email: ___________________________________________________ ADHD Parents Medication Guide – July 2013 2 Introduction Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by difficulty paying attention, excessive activity, and impulsivity (acting before you think). ADHD is usually identified when children are in grade school but can be diagnosed at any time from preschool to adulthood. Recent studies indicate that almost 10 percent of children between the ages of 4 to 17 are reported by their parents as being diagnosed with ADHD. So in a classroom of 30 children, two to three children may have ADHD.1,2,3,4,5 Short attention spans and high levels of activity are a normal part of childhood. For children with ADHD, these behaviors are excessive, inappropriate for their age, and interfere with daily functioning at home, school, and with peers. Some children with ADHD only have problems with attention; other children only have issues with hyperactivity and impulsivity; most children with ADHD have problems with all three. As they grow into adolescence and young adulthood, children with ADHD may become less hyperactive yet continue to have significant problems with distraction, disorganization, and poor impulse control. ADHD can interfere with a child’s ability to perform in school, do homework, follow rules, and develop and maintain peer relationships. When children become adolescents, ADHD can increase their risk of dropping out of school or having disciplinary problems.
    [Show full text]
  • Pharmacist-Physician Team Approach to Medication-Therapy
    Pharmacist-Physician Team Approach to Medication-Therapy Management of Hypertension The following is a synopsis of “Primary-Care-Based, Pharmacist-Physician Collaborative Medication-Therapy Management of Hypertension: A Randomized, Pragmatic Trial,” published online in June 2014 in Clinical Therapeutics. What is already known on this topic? found that the role of the pharmacist differed within each study; whereas some pharmacists independently initiated and High blood pressure, also known as hypertension, is a changed medication therapy, others recommended changes major risk factor for cardiovascular disease, the leading to physicians. Pharmacists were already involved in care in all cause of death for U.S. adults. Helping patients achieve but one study. blood pressure control can be difficult for some primary care providers (PCPs), and this challenge may increase with After reviewing the RCTs, the authors conducted a randomized the predicted shortage of PCPs in the United States by 2015. pragmatic trial to investigate the processes and outcomes that The potential shortage presents an opportunity to expand result from integrating a pharmacist-physician team model. the capacity of primary care through pharmacist-physician Participants were randomly selected to receive PharmD-PCP collaboration for medication-therapy management (MTM). MTM or usual care from their PCPs. The authors conducted MTM performed through a collaborative practice agreement the trial within a university-based internal medicine medical allows pharmacists to initiate and change medications. group where the collaborative PharmD-PCP MTM team Researchers have found positive outcomes associated included an internal medicine physician and two clinical with having a pharmacist on the care team; however, the pharmacists, both with a Doctor of Pharmacy degree, at least evidence is limited to only a few randomized controlled 1 year of pharmacy practice residency training, and more than trials (RCTs).
    [Show full text]
  • Pharmacy/Medical Drug Prior Authorization Form
    High Cost Medical Drugs List High Cost Medical Drugs administered by Health Alliance™ providers within physician offices, infusion centers or hospital outpatient settings must be acquired from preferred specialty vendors. Health Alliance will not reimburse any drug listed as a “High Cost Medical Drug,” whether obtained from the provider’s own stock or via “buy-and-bill.” This drug list does not apply to members with Medicare coverage. Information on how to acquire these medications is located at the end of this document. Recent Updates Preferred Contact Drug Therapy Drug Name Code PA Effective Change Vendor Number Oncology – Injectable DARZALEX FASPRO J9144 YES 10/1/2021 CVS/Caremark® 800-237-2767 Added High Cost Medical Drug List Preferred Contact Drug Therapy Drug Name Code PA Effective Vendor Number Acromegaly SANDOSTATIN J2353 YES 7/1/2020 CVS/Caremark® 800-237-2767 Acromegaly SOMATULINE J1930 YES 7/1/2020 CVS/Caremark® 800-237-2767 Additional Products JETREA J7316 YES 7/1/2020 LDD Additional Products PROLASTIN J0256 YES 7/1/2020 LDD Additional Products QUTENZA J7336 NO 7/1/2020 LDD Additional Products REVCOVI J3590 YES 7/1/2020 LDD Additional Products RADICAVA J1301 YES 7/1/2020 CVS/Caremark® 800-237-2767 Additional Products SIGNIFOR J2502 YES 7/1/2020 Accredo® 866-759-1557 Additional Products SPRAVATO J3490 YES 7/1/2020 CVS/Caremark® 800-237-2767 Additional Products STRENSIQ J3590 YES 7/1/2020 LDD Additional Products THIOTEPA J9340 YES 7/1/2020 CVS/Caremark® 800-237-2767 Allergic Asthma CINQAIR J2786 YES 7/1/2020 CVS/Caremark® 800-237-2767
    [Show full text]
  • Beta Blocker
    Medication Information Beta Blocker Other names for this medication Acebutol Nadolol Atenolol Pindolol Bisoprolol Propanolol Carvediol Sotalol Labetalol Timolol Metoprolol There are many other names for this medication. How this medication is used This medication causes your heart to beat slower. This helps rest the heart after a heart attack. This medication helps prevent and/or reduce chest pain and irregular heart beats. It does not stop chest pain or angina after the pain has started. Bisoprolol, Carvedilol and Metoprolol can be used to prevent heart failure. They work by relaxing the blood vessels. This allows more blood to go to the heart. The more blood that goes to the heart, the more oxygen the heart gets. This helps the heart work better. Some of these medications are used to treat high blood pressure, migraine headaches and muscle tremors. Beta Blocker How to take this medication Take this medication exactly as directed by your doctor or health care provider. It must be taken regularly, even if you feel well. Do not suddenly stop taking this medication without checking with your doctor or health care provider first. Suddenly stopping this medication can cause: • chest pain • irregular heart beats • high blood pressure. When it is time to stop taking this medication your doctor or health care provider may slowly decrease the amount. If you miss a dose of this medication, take it as soon as possible. However, if it is almost time for the next dose, skip the missed dose and go back to your regular time. Do not take 2 doses at one time.
    [Show full text]
  • ASHP Statement on Pharmaceutical Care
    Medication Therapy and Patient Care: Organization and Delivery of Services–Statements 331 ASHP Statement on Pharmaceutical Care The purpose of this statement is to assist pharmacists in under- Care. Central to the concept of care is caring, a personal standing pharmaceutical care. Such understanding must pre- concern for the well-being of another person. Overall cede efforts to implement pharmaceutical care, which ASHP patient care consists of integrated domains of care including believes merit the highest priority in all practice settings. (among others) medical care, nursing care, and pharmaceu- Possibly the earliest published use of the term pharma- tical care. Health professionals in each of these disciplines ceutical care was by Brodie in the context of thoughts about possess unique expertise and must cooperate in the patient’s drug use control and medication-related services.1,2 It is a overall care. At times, they share in the execution of the various term that has been widely used and a concept about which types of care (including pharmaceutical care). To pharma- much has been written and discussed in the pharmacy pro- ceutical care, however, the pharmacist contributes unique fession, especially since the publication of a paper by Hepler knowledge and skills to ensure optimal outcomes from the and Strand in 1990.3–5 ASHP has formally endorsed the con- use of medications. cept.6 With varying terminology and nuances, the concept At the heart of any type of patient care, there exists a has also been acknowledged by other national pharmacy or- one-to-one relationship between a caregiver and a patient.
    [Show full text]
  • Intensive Care Units (ICU): the Clinical Pharmacist Role to Improve Clinical Outcomes and Reduce Mortality Rate- an Undeniable Function
    Open Access Journal of Clinical Intensive Care and Medicine Review Article Intensive Care Units (ICU): The clinical pharmacist role to improve clinical ISSN 2639-6653 outcomes and reduce mortality rate- An undeniable function Luisetto M1* and Ghulam Rasool Mashori2 1Applied Pharmacologist, Hospital Pharmacist Manager 29121, Italy 2Professor & Director, Peoples University of Medcial & Health Sciences for Woman, Nawabshah, Pakistan *Address for Correspondence: Luisetto M, Applied Abstract Pharmacologist, Hospital Pharmacist Manager 29121, Italy, Email: [email protected] Observing relevant biomedical literature we have see that clinical pharmacist play a crucial role in ICU Submitted: 09 October 2017 settings with reducing in mortality rate and improving some clinical outcomes. Approved: 01 November 2017 Published: 02 November 2017 Copyright: 2017 Luisetto M, et al. This is Introduction an open access article distributed under the Creative Commons Attribution License, which In ICU settings we can easily observe that the mortality rate is higher then other permits unrestricted use, distribution, and wards and for this reason a real multisiciplinatity medical team with added clinical ph. reproduction in any medium, provided the Competences can improve this situation. High intensity of cure, polipharmacy, critical original work is properly cited. patient conditions need also a pharmaceutical competencies to be added to the classic Keywords: ICU; Clinical pharmacy; Pharmaceutical decision making systems (clinical- managerial). The critically hill patients need a more care; Clinical outcomes; Mortality rate rational decision making systems to improve the clinical outcomes and in safety way. Material and Methods In this review and research paper we have searched some relevant biomedical literature in order to evaluate the real eficacy of clinical pharmacist in improving clinical outcomes and reducing mortality rate.
    [Show full text]
  • Pharmacology 101
    Pharmacology 101 Tyler Fischback, PharmD, BCPS, DPLA Clinical Pharmacy Manager Confluence Health Wenatchee, WA Objectives • Define Pharmacology, Pharmacokinetics and Pharmacodynamics • Understand how drug interactions work • Understand how some specific drugs behave in the body (opioids, benzodiazepines, amiodarone) • Apply pharmacology principles into practice Medication Errors and Adverse Drug Events • Error: An error of commission or omission at any step along the pathway that begins when a clinician prescribes a medication and ends when the patient actually received the medication. • ADE: Harm experienced by a patient as a result of exposure to a medication. ADE does not necessarily indicate an error or poor care. However, ~1/2 of ADEs are preventable. Anyone here ever seen a medication error or adverse drug event? Anyone here ever made a medication error? How many different prescription medications are available on the U.S. market? 1,000 So, it’s no surprise why we see so many problems………………… EXCEPT……. The real number is 10,000 Adverse Drug Events • ~1/3 of U.S. adults use 5 or more medications • Annually, ADE = 700,000 ER visits and 100,000 hospitalizations • So, is pharmacology important to your work? • Additionally, 5% of hospitalized patient experience an ADE during their stay • High risk: Anticoagulants, Opioids, Insulin, Cardiac, and Transitions of Care Adverse Drug Events, cont. • Elderly are more susceptible • Pediatrics patients more susceptible (weight-based dosing), especially liquids • Caregivers and patients admittedly
    [Show full text]
  • Current Status of Immunology Education in US Schools And
    American Journal of Pharmaceutical Education 2019; 83 (7) Article 6994. RESEARCH Current Status of Immunology Education in US Schools and Colleges of Pharmacy Yuan Zhao, PhD,a Dana Ho, PharmD,a Benjamin Oldham, PharmD,a Bonnie Dong, PharmD,a Daniel Malcom, PharmDa,b a Sullivan University College of Pharmacy, Louisville, Kentucky b Associate Editor, American Journal of Pharmaceutical Education, Arlington, Virginia Submitted February 2, 2018; accepted June 17, 2018; published September 2019. Objective. To determine the extent of immunology education in US Doctor of Pharmacy (PharmD) programs. Methods. Curricular information on immunology education was collected from the web pages of US PharmD programs (N5142). The data were sorted, comparisons were made, and trends were identified. Results. Of 142 PharmD programs studied, 100% posted curriculum information on their websites. Among them, 73 programs (51.4%) had a dedicated immunology course in their curriculum, either as an independent course or a course combined with another subject. Most immunology education was offered in the first professional year (72.5%). Of the programs that offered immunology as an in- dependent course, the number of semester hours dedicated to the course varied from 1.5 to 3.5 (median53, mode53, mean52.7). More three-year programs offered immunology as a core compo- nent in the didactic curriculum than did four-year programs (64.7% vs 49.6%). Similarly, more private programs offered immunology than did public programs (64% vs 37.3%). Conclusion. Immunology education in US schools and colleges of pharmacy lacks consensus. Not all PharmD programs indicated they offered specific, focused immunology education in their curricula.
    [Show full text]